Advertisement

Editor Profile

Larry M. Baddour, MD

Editor-in-Chief

About the NEJM Journal Watch Infectious Diseases Board

Larry M. Baddour, MD, FIDSA, FAHA, is the HH Sheikh Khalifa Bin Zayed Al-Nahyan Professor of Infectious Diseases Honoring Walter R. Wilson, MD, and Chair, Division of Infectious Diseases at Mayo Clinic College of Medicine, Rochester, Minnesota. He has career-long interests in skin and soft-tissue infections and cardiovascular infections. He provided the initial clinical description of postvenectomy cellulitis among coronary artery bypass patients, in 1982. He also provided an early description of breast cellulitis complicating breast conservation therapy. He has analyzed risk factors for this complication and for lower-extremity cellulitis. Dr. Baddour’s laboratory and clinical work on cardiovascular infections has yielded more than 100 publications. A member of the American Heart Association’s Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee since 1999, he has first-authored three Scientific Statements for the group and now serves as Chairman. Dr. Baddour began editing and writing for NEJM Journal Watch Infectious Diseases in 2007.

Disclosures

Royalties

UpToDate, Inc. (Authorship duties)

Summaries by Larry Baddour

  • March 18, 2015

    Therapy for Uncomplicated Skin InfectionsFree

    1. Larry M. Baddour, MD

    In a trial conducted at four medical centers in regions where community-acquired methicillin-resistant Staphylococcus aureus is endemic, cure rates were similar between trimethoprim-sulfamethoxazole and clindamycin.

  • March 4, 2015

    Efficacy of a Hepatitis E Vaccine

    1. Larry M. Baddour, MD

    A recombinant vaccine was immunogenic and protective for up to 4.5 years.

  • February 25, 2015

    Clostridium difficile Infection in the U.S.
    Free

    1. Larry M. Baddour, MD

    Survey data suggest that the burden of CDI may be higher than previously projected.

  • February 25, 2015

    Healthcare-Associated MERS-CoV OutbreakFree

    1. Larry M. Baddour, MD

    Healthcare exposure was the predominant factor driving the 2014 Middle East respiratory syndrome coronavirus outbreak in Jeddah, Saudi Arabia.

  • February 18, 2015

    Mass Treatment for Yaws

    1. Larry M. Baddour, MD

    On a Papua New Guinean island where yaws was endemic, one round of oral azithromycin significantly reduced the prevalence of this disease.

  • February 3, 2015

    Ebola Vaccine — Progress Made

    1. Larry M. Baddour, MD

    A monovalent chimpanzee adenovirus vaccine was immunogenic and safe in humans.

Pages